On the basis of their results the authors concluded that the incidence of CIN in patients with multiple myeloma with a normal serum creatinine is low and correlates with β2-microglobulin levels; thus, the administration of contrast agents in these patients is relatively safe [102]. The gene discussed is HLA-G; the disease is cervical squamous intraepithelial neoplasia.